BioWales 2009: Size does matter
This article was originally published in Clinica
Executive Summary
£1.3bn ($1.84bn) is the figure quoted most frequently in answer to the question: What is the value of the bioscience industry in Wales? But that figure is a year old, and undersells a dynamic and growing sector. So says MediWales forum manager Gwyn Tudor.
You may also be interested in...
“We Can’t Do It All Alone” Pfizer UK Tells Life Sciences Meeting
Incoming Pfizer UK country manager Ben Osborn outlined the delivery challenges ahead for health-care systems globally at the BioWales Showcase, in London in late February.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.